Geron
GERN
#6480
Rank
โ‚น90.57 B
Marketcap
โ‚น141.18
Share price
0.00%
Change (1 day)
18.42%
Change (1 year)

Revenue for Geron (GERN)

Revenue in 2026 (TTM): โ‚น17.55 Billion

According to Geron's latest financial reports the company's current revenue (TTM ) is โ‚น18.70 Billion. In 2025 the company made a revenue of โ‚น16.50 Billion an increase over the revenue in the year 2024 that were of โ‚น6.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Geron from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น17.55 B6.35%
2025 โ‚น16.50 B149.91%
2024 โ‚น6.60 B33377.25%
2023 โ‚น19.72 M-60%
2022 โ‚น49.31 M-52.43%
2021 โ‚น0.10 B460.36%
2020 โ‚น18.5 M-43.59%
2019 โ‚น32.8 M-55.99%
2018 โ‚น74.53 M9.61%
2017 โ‚น68 M-83.76%
2016 โ‚น0.41 B-82.68%
2015 โ‚น2.41 B3207.62%
2014 โ‚น73.07 M-7.81%
2013 โ‚น79.26 M-46.56%
2012 โ‚น0.14 B15.01%
2011 โ‚น0.12 B-19.22%
2010 โ‚น0.15 B99.36%
2009 โ‚น80.08 M-40.56%
2008 โ‚น0.13 B-54.96%
2007 โ‚น0.29 B106.1%
2006 โ‚น0.14 B1012.17%
2005 โ‚น13.05 M
2003 โ‚น43.16 M-20.84%
2002 โ‚น54.52 M-68.78%
2001 โ‚น0.17 B-43.37%
2000 โ‚น0.30 B30.28%
1999 โ‚น0.23 B-18.12%
1998 โ‚น0.28 B0.78%
1997 โ‚น0.28 B50.57%
1996 โ‚น0.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚น2.836 T 15,061.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น511.41 B 2,633.61%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น7.22 B-61.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น115.50 B 517.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA